Celltrion
068270.KS
HK$1,018
Share price
0.00%
Change (1 day)
1.02%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Total assets
Total assets on the balance sheet as of March 2025 : HK$111.76 Billion
According to Celltrion 's latest financial reports the company's total assets are HK$111.76 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Celltrion - Total assets on balance sheet (from 2007 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | HK$111.39 B | -7.55% |
| 2023-12-31 | HK$120.49 B | 230.05% |
| 2022-12-31 | HK$36.50 B | -1.82% |
| 2021-12-31 | HK$37.18 B | 3.8% |
| 2020-12-31 | HK$35.82 B | 37.8% |
| 2019-12-31 | HK$25.99 B | 5.78% |
| 2018-12-31 | HK$24.57 B | 1.79% |
| 2017-12-31 | HK$24.14 B | 30.13% |
| 2016-12-31 | HK$18.55 B | 6.52% |
| 2015-12-31 | HK$17.41 B | 5.89% |
| 2014-12-31 | HK$16.44 B | 13.02% |
| 2013-12-31 | HK$14.55 B | 12.46% |
| 2012-12-31 | HK$12.93 B | 37.25% |
| 2011-12-31 | HK$9.42 B | 18.17% |
| 2010-12-31 | HK$7.97 B | 111.8% |
| 2009-12-31 | HK$3.76 B | 21.28% |
| 2008-12-31 | HK$3.10 B | 500.39% |
| 2007-12-31 | HK$0.51 B |